Stanford Says Its DNA Patent Is 'Antithesis' Of Prior Art
Stanford University urged a Federal Circuit panel Thursday to revive a DNA sequencing patent scrapped by the Patent Trial and Appeals Board following a challenge by Ariosa Diagnostics Inc., saying the...To view the full article, register now.
Already a subscriber? Click here to view full article